U.S.-listed Chinese Stocks May Be Set for Rebound in 2022

After a year of setbacks, Chinese stocks traded in New York and Hong Kong are regaining investor interest as the policy landscape becomes clearer Key takeaways: The regulatory storm that decimated U.S.-listed Chinese stocks last year is winding down, with shares likely to recover lost ground in 2022 By lowering the threshold for second listings, the Hong Kong Stock Exchange is becoming more attractive to mid-cap U.S.-listed Chinese companies. By Tina Yip Last year was a time international investors in Chinese stocks would rather forget. Hong Kong shares of Alibaba…

Read More »

Zepp Health Stuck in Rut as Global Chip Shortage, Covid Weigh

Smart wearables maker cuts fourth-quarter revenue guidance, but expects to stay profitable, as competition intensifies Key takeaways: Zepp Health has cut its fourth-quarter revenue guidance, sending its shares to near all-time lows, as its shipments fall due to overreliance on Xiaomi relationship Global chip shortage and fresh Covid restrictions are also weighing on company as it tries to gain share in the crowded global smartwatch space By Mia Shanley Smart wearable device maker Zepp Health’s (ZEPP.US) efforts to carve out a niche in the crowded global smartwatch space are being…

Read More »